HeartSciences Inc.
Cash Flow Statement
| Line Item | Jan 2026 | Oct 2025 | Jul 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.0M | $-2.4M | $-2.1M | $-2.5M | $-2.1M | $-2.1M | $-1.6M | $-1.7M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | $7.1K | — | — | $11.9K | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | $174.6K | — | — | $54.6K | — | — |
| Net Cash from Operating Activities | $-1.5M | $-2.3M | $-2.0M | $-1.6M | $-2.2M | $-2.0M | $-2.1M | $-988.2K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | $8.8K | $2.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $-814 | — | — | $-833 | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $3.6M | — | — | $551.7K | — | — |
| Net Change in Cash | — | — | $1.7M | — | — | $-1.5M | — | — |
| Free Cash Flow | — | — | — | — | — | — | $-2.1M | $-990.1K |